Lumosa Therapeutics and CHI Memorial announce new study for acute stroke
TAIPEI and CHATTANOOGA, Tenn., Feb. 2, 2024 /PRNewswire/ — Lumosa Therapeutics (Lumosa; 6535.TWO), together with CHI Memorial have announced the initiation
Read MoreTAIPEI and CHATTANOOGA, Tenn., Feb. 2, 2024 /PRNewswire/ — Lumosa Therapeutics (Lumosa; 6535.TWO), together with CHI Memorial have announced the initiation
Read MoreGENEVA, Oct. 27, 2023 /PRNewswire/ — The World Stroke Organization (WSO) is calling on governments and healthcare systems to implement
Read MoreMUNICH, May 23, 2023 /PRNewswire/ — Researchers from Denmark have developed a new artificial intelligence (AI) framework to address the number
Read MoreGENEVA, Switzerland, Oct. 28, 2022 /PRNewswire/ — On World Stroke Day (29th Oct), the World Stroke Organization has announced the
Read MoreLYON, France, May 3, 2022 /PRNewswire/ — A new study has identified strains of gut microbiota that are associated with
Read More